Atezolizumab (atezo) + bevacizumab (bev) versus sunitinib (sun) in pts with untreated metastatic renal cell carcinoma (mRCC) and sarcomatoid (sarc) histology: IMmotion151 subgroup analysis.
暂无分享，去创建一个
C. Porta | A. Ravaud | R. Motzer | T. Powles | M. Atkins | B. Rini | B. Escudier | J. Bedke | S. Bracarda | R. Hawkins | F. Donskov | D. McDermott | E. Grande | U. Giorgi | C. Schiff | F. Parnis | Susheela Y. Carroll | Wei Zhang | R. Sufan | M. Huseni | S. Carroll